Novavax

Gaithersburg, MoCo February 20, 2021

Gaithersburg-Based Novavax Reaches Agreement to Provide 1.1 Billion Doses of Covid Vaccine Globally

Gaithersburg-Based Novavax Reaches Agreement to Provide 1.1 Billion Doses of Covid Vaccine Candidate Globally Per Novavax: Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation…

Gaithersburg January 29, 2021

Gaithersburg-Based Novavax Releases Covid Vaccine Trial Data

Gaithersburg-Based Novavax Releases Covid Vaccine Trial Data Novavax conducted a 15,000-person trial in the United Kingdom, and their early analysis suggests 90 percent efficacy after…